J3230 HCPCS code: Injection, chlorpromazine hcl, up to 50 mg
J3230 is the HCPCS Level II code for injection, chlorpromazine hcl, up to 50 mg. In 2023 Medicare paid an average of $17.23 per service for J3230 across 17 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 6 per day on outpatient hospital claims. Medicare volume rose 31% from 2022 to 2023 (13 to 17 services). In 2023, about 15 clinicians billed Medicare for J3230 for 15 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 1997-01-01 |
Who bills J3230 (2023)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 15 |
| Medicare beneficiaries | 15 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3230, 2022–2023
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 13 | 11 | $13.49 | $10.57 |
| 2023 | 17 | 15 | $23.09 | $17.23 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 6 | Clinical: Data |
| practitioner claims | 2 | Clinical: Data |
What changed for J3230
- 1982-01-01: J3230 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3230?
J3230 is the HCPCS Level II code for injection, chlorpromazine hcl, up to 50 mg. Short descriptor: "Chlorpromazine hcl injection".
How much does Medicare pay for J3230?
In 2023, the average Medicare payment was $17.23 per service (average allowed $23.09).
Does Medicare cover J3230?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J3230 can be billed per day?
6 on outpatient hospital claims; 2 on practitioner claims (NCCI medically unlikely edits).
Related J32 codes
- J3240 — Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
- J3241 — Injection, teprotumumab-trbw, 10 mg
- J3243 — Injection, tigecycline, 1 mg
- J3244 — Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245 — Injection, tildrakizumab, 1 mg
- J3246 — Injection, tirofiban hcl, 0.25 mg
- J3247 — Injection, secukinumab, intravenous, 1 mg
- J3250 — Injection, trimethobenzamide hcl, up to 200 mg
- J3260 — Injection, tobramycin sulfate, up to 80 mg
- J3262 — Injection, tocilizumab, 1 mg
- J3263 — Injection, toripalimab-tpzi, 1 mg
- J3265 — Injection, torsemide, 10 mg/ml
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3230
- Watch J3230 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3230
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.